Serum apolipoprotein A1 and B are associated with 6-month persistent and incident diabetic macular oedema in type 2 diabetes

MLA

Muhammad Bayu Sasongko, et al. “Serum Apolipoprotein A1 and B Are Associated with 6-Month Persistent and Incident Diabetic Macular Oedema in Type 2 Diabetes.” BMJ Open Ophthalmology, vol. 8, no. 1, June 2023. EBSCOhost, https://doi.org/10.1136/bmjophth-2022-001207.

APA

Muhammad Bayu Sasongko, Madarina Julia, Soefiandi Soedarman, Tjahjono D Gondhowiardjo, Alberthus Donni Budi Prasetya, & King Hans Kurnia. (2023). Serum apolipoprotein A1 and B are associated with 6-month persistent and incident diabetic macular oedema in type 2 diabetes. BMJ Open Ophthalmology, 8(1). https://doi.org/10.1136/bmjophth-2022-001207

Chicago

Muhammad Bayu Sasongko, Madarina Julia, Soefiandi Soedarman, Tjahjono D Gondhowiardjo, Alberthus Donni Budi Prasetya, and King Hans Kurnia. 2023. “Serum Apolipoprotein A1 and B Are Associated with 6-Month Persistent and Incident Diabetic Macular Oedema in Type 2 Diabetes.” BMJ Open Ophthalmology 8 (1). doi:10.1136/bmjophth-2022-001207.